相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The evolution of bispecific antibodies
Nimish Gera
EXPERT OPINION ON BIOLOGICAL THERAPY (2022)
Rational selection of building blocks for the assembly of bispecific antibodies
Danyang Gong et al.
MABS (2021)
Discovery of amivantamab (JNJ-61186372), a bispecific antibody targeting EGFR and MET
Joost Neijssen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Bispecific Antibodies: From Research to Clinical Application
Jiabing Ma et al.
FRONTIERS IN IMMUNOLOGY (2021)
The state of the art of bispecific antibodies for treating human malignancies
Shuhang Wang et al.
EMBO MOLECULAR MEDICINE (2021)
Low immunogenicity of emicizumab in persons with haemophilia A
Christophe Schmitt et al.
HAEMOPHILIA (2021)
T cell-engaging therapies - BiTEs and beyond
Maria-Elisabeth Goebeler et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
A systematic mutational analysis identifies a 5-residue proline tag that enhances thein vivoimmunogenicity of a non-immunogenic model protein
Nafsoon Rahman et al.
FEBS OPEN BIO (2020)
Intein mediated high throughput screening for bispecific antibodies
Tim Hofmann et al.
MABS (2020)
Investigation of pre-existing reactivity to biotherapeutics can uncover potential immunogenic epitopes and predict immunogenicity risk
Nicoletta Bivi et al.
MABS (2019)
Arginine to Lysine Mutations Increase the Aggregation Stability of a Single-Chain Variable Fragment through Unfolded-State Interactions
James I. Austerberry et al.
BIOCHEMISTRY (2019)
Elucidating heavy/light chain pairing preferences to facilitate the assembly of bispecific IgG in single cells
Kamal Kishore Joshi et al.
MABS (2019)
Bispecific antibodies: a mechanistic review of the pipeline
Aran F. Labrijn et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Protein aggregation and mitigation strategy in low pH viral inactivation for monoclonal antibody purification
Weixin Jin et al.
MABS (2019)
Engineering a bispecific antibody with a common light chain: Identification and optimization of an anti-CD3 epsilon and anti-GPC3 bispecific antibody, ERY974
Hirotake Shiraiwa et al.
METHODS (2019)
Electrostatic Interactions in Protein Structure, Folding, Binding, and Condensation
Huan-Xiang Zhou et al.
CHEMICAL REVIEWS (2018)
Expanding the Boundaries of Biotherapeutics with Bispecific Antibodies
Bushra Husain et al.
BIODRUGS (2018)
Variable heavy-variable light domain and Fab-arm CrossMabs with charged residue exchanges to enforce correct light chain assembly
Joerg Thomas Regula et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2018)
Efficient production of bispecific IgG of different isotypes and species of origin in single mammalian cells
Michael Dillon et al.
MABS (2017)
The effect of charge mutations on the stability and aggregation of a human single chain Fv fragment
James I. Austerberry et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2017)
A new approach for generating bispecific antibodies based on a common light chain format and the stable architecture of human immunoglobulin G1
Camilla De Nardis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Immunoglobulin domain interface exchange as a platform technology for the generation of Fc heterodimers and bispecific antibodies
Darko Skegro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
The making of bispecific antibodies
Ulrich Brinkmann et al.
MABS (2017)
Emicizumab Prophylaxis in Hemophilia A with Inhibitors
Johannes Oldenburg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Generation of human bispecific common light chain antibodies by combining animal immunization and yeast display
Simon Krah et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2017)
An anti-glypican 3/CD3 bispecific T cell-redirecting antibody for treatment of solid tumors
Takahiro Ishiguro et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Advances in recombinant antibody manufacturing
Renate Kunert et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2016)
Aberrant bispecific antibody pharmacokinetics linked to liver sinusoidal endothelium clearance mechanism in cynomolgus monkeys
Amita Datta-Mannan et al.
MABS (2016)
A Novel Antibody Engineering Strategy for Making Monovalent Bispecific Heterodimeric IgG Antibodies by Electrostatic Steering Mechanism
Zhi Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Protein A chromatography increases monoclonal antibody aggregation rate during subsequent low pH virus inactivation hold
Alice R. Mazzer et al.
JOURNAL OF CHROMATOGRAPHY A (2015)
Improving target cell specificity using a novel monovalent bispecific IgG design
Yariv Mazor et al.
MABS (2015)
Non-antigen-contacting region of an asymmetric bispecific antibody to factors IXa/X significantly affects factor VIII-mimetic activity
Zenjiro Sampei et al.
MABS (2015)
Lysine and Arginine Content of Proteins: Computational Analysis Suggests a New Tool for Solubility Design
Jim Warwicker et al.
MOLECULAR PHARMACEUTICS (2014)
Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface
Steven M. Lewis et al.
NATURE BIOTECHNOLOGY (2014)
Structure-Based Prediction of Asparagine and Aspartate Degradation Sites in Antibody Variable Regions
Jasmin F. Sydow et al.
PLOS ONE (2014)
Conformational Selection in Substrate Recognition by Hsp70 Chaperones
Moritz Marcinowski et al.
JOURNAL OF MOLECULAR BIOLOGY (2013)
Bispecific antibodies with natural architecture produced by co-culture of bacteria expressing two distinct half-antibodies
Christoph Spiess et al.
NATURE BIOTECHNOLOGY (2013)
Identification and Multidimensional Optimization of an Asymmetric Bispecific IgG Antibody Mimicking the Function of Factor VIII Cofactor Activity
Zenjiro Sampei et al.
PLOS ONE (2013)
Aggregation Mechanism of an IgG2 and two IgG1 Monoclonal Antibodies at low pH: From Oligomers to Larger Aggregates
Paolo Arosio et al.
PHARMACEUTICAL RESEARCH (2013)
Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange
Aran F. Labrijn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Beyond humanization and de-immunization: tolerization as a method for reducing the immunogenicity of biologics
Anne S. De Groot et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2013)
Elucidation of Acid-induced Unfolding and Aggregation of Human Immunoglobulin IgG1 and IgG2 Fc
Ramil F. Latypov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Simultaneous detection and analysis of protein aggregation and protein unfolding by size exclusion chromatography with post column addition of the fluorescent dye BisANS
Miriam Printz et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model
Takehisa Kitazawa et al.
NATURE MEDICINE (2012)
Engineering the variable region of therapeutic IgG antibodies
Tomoyuki Igawa et al.
MABS (2011)
Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies
Wolfgang Schaefer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Enhancing Antibody Fc Heterodimer Formation through Electrostatic Steering Effects APPLICATIONS TO BISPECIFIC MOLECULES AND MONOVALENT IgG
Kannan Gunasekaran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
VH/VL interface engineering to promote selective expression and inhibit conformational isomerization of thrombopoietin receptor agonist single-chain diabody
Tomoyuki Igawa et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2010)
Stability engineering of scFvs for the development of bispecific and multivalent antibodies
Brian R. Miller et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2010)
SEEDbodies: fusion proteins based on strand-exchange engineered domain (SEED) CH3 heterodimers in an Fc analogue platform for asymmetric binders or immunofusions and bispecific antibodies
Jonathan H. Davis et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2010)
How antibodies fold
Matthias J. Feige et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
An Unfolded CH1 Domain Controls the Assembly and Secretion of IgG Antibodies
Matthias J. Feige et al.
MOLECULAR CELL (2009)
Anti-tumor activity of stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LTβR
Jennifer S. Michaelson et al.
MABS (2009)
Activation of natural regulatory T cells by IgG Fc-derived peptide Tregitopes
Anne S. De Groot et al.
BLOOD (2008)
Prediction of immunogenicity: in silico paradigms, ex vivo and in vivo correlates
Anne S. De Groot et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
Extrinsic fluorescent dyes as tools for protein characterization
Andrea Hawe et al.
PHARMACEUTICAL RESEARCH (2008)